GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | CLDI | INAB | ||
| Company | GT Biopharma Inc | Calidi Biotherapeutics Inc | In8Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.8650 | 1.2500 | 1.92 | ||
| High | 0.8700 | 1.2800 | 2.24 | ||
| Low | 0.7821 | 1.2100 | 1.82 | ||
| Latest | 0.8324 | 1.2400 | 2.23 | ||
| Change | -0.0126 | -0.0500 | +0.23 | ||
| % Change | -1.49% | -3.88% | +11.50% | ||
| Volume | 1,954,600 | 46,000 | 291,300 | ||
| 20-Day Average Volume | 1,632,485 | 68,400 | 667,015 | ||
| Previous Close | 0.8450 | 1.2900 | 2.00 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7120 | 1.4060 | 1.72 | ||
| 20-Day Raw Stochastic | 87.00% | 8.82% | 99.07% | ||
| 20-Day Relative Strength | 56.68 | 38.97 | 61.43 | ||
| Weighted Alpha | -77.99 | -91.59 | -69.06 | ||
| Today's Opinion | 40% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 40% Sell | 100% Sell | 56% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Sell | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.30% since 12/18/25 | -5.34% since 12/18/25 | +61.59% since 12/18/25 | ||
| Low | 0.7120 on 12/19/25 | 1.2100 on 12/26/25 | 1.17 on 12/19/25 | ||
| High | 0.8700 on 12/26/25 | 1.4500 on 12/22/25 | 2.24 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | +3.82% since 11/26/25 | -16.22% since 11/26/25 | +10.95% since 11/26/25 | ||
| Low | 0.5808 on 12/03/25 | 1.2100 on 12/26/25 | 1.17 on 12/19/25 | ||
| High | 0.8700 on 12/26/25 | 1.5500 on 12/05/25 | 2.24 on 12/26/25 | ||
| 3-Month | |||||
| %Chg | +8.39% since 09/26/25 | -21.02% since 09/26/25 | -2.62% since 09/26/25 | ||
| Low | 0.5400 on 11/07/25 | 1.1000 on 11/07/25 | 1.17 on 12/19/25 | ||
| High | 1.3700 on 10/08/25 | 1.7400 on 10/15/25 | 2.65 on 10/08/25 | ||
| 6-Month | |||||
| %Chg | -78.09% since 06/26/25 | -54.88% since 06/26/25 | +3.24% since 06/26/25 | ||
| Low | 0.5400 on 11/07/25 | 1.1000 on 11/07/25 | 1.17 on 12/19/25 | ||
| High | 3.8500 on 06/27/25 | 19.2000 on 07/09/25 | 2.65 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,987 | 9,246 | 8,437 | ||
| Shares Outstanding, K | 10,636 | 7,168 | 4,218 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -13,160,000 | -22,140,000 | -30,440,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -3,110,000 | -5,150,000 | -3,850,000 | ||
| 60-Month Beta | 1.52 | 1.08 | 0.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 11/14/25 | -2.21 on 11/13/25 | -0.85 on 11/06/25 | ||
| Latest Earnings Date | 02/20/26 | 03/30/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||